← FDA Drug Approvals (Drugs@FDA)

DATROWAY

BLA · Biologics License Application · Sponsor: DAIICHI SANKYO INC · Approved 2025-06-23

Drug application

FDA Application #

BLA761464

Application type

Biologics License Application

Brand name

DATROWAY

Generic name

Datopotamab Deruxtecan-Dlnk

Active ingredients

DATOPOTAMAB DERUXTECAN-DLNK

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

DAIICHI SANKYO INC

First approval

2025-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown